DOJ Resolves Criminal Price Fixing Charges With Deferred ...

Major Generic Drug Companies to Pay Over Quarter of a Billion ...

The Justice Department announced today deferred prosecution agreements resolving criminal antitrust charges against Teva Pharmaceuticals USA, ...

The DOJ's recent resolution of criminal antitrust charges against Teva and Glenmark is notable for the use of deferred prosecution ...

DOJ Enters into Unprecedented Deferred Prosecution Agreements ...

The Teva and Glenmark DPAs mark the sixth and seventh companies to resolve criminal charges in the DOJ's broader investigation into price-fixing ...

DOJ Resolves Criminal Price Fixing Charges With Deferred ...

The DOJ's recent resolution of criminal antitrust charges against Teva and Glenmark is notable for the use of deferred prosecution agreements (DPAs) rather ...

Pharmaceutical Company Admits to Price Fixing in Violation of ...

The Antitrust Division also announced a deferred prosecution agreement resolving the charge, under which Heritage admits that it conspired to ...

DOJ Antitrust Division Announces Deferred Prosecution Agreements ...

The agreements resolve antitrust charges against the companies and bring to a close a series of criminal prosecutions that the Antitrust ...

Drug Maker Teva Pharmaceuticals Agrees to Pay $450M in False ...

Teva USA previously entered into a deferred prosecution agreement with the Justice Department's Antitrust Division to resolve related criminal ...

DOJ Criminal Antitrust Settlements Involve Dollars, Donations, and ...

On August 21, the U.S. Department of Justice (DOJ), Antitrust Division announced deferred prosecution agreements (DPAs) resolving criminal ...

Deferred Prosecution Agreements in Antitrust Enforcement

The use of DPAs in criminal antitrust prosecutions provides a promising new avenue for the DOJ to preserve government resources while maintaining the general ...

Pharmaceutical Company Pays $25 Million to Resolve Alleged ...

Pharmaceutical Company Pays $25 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug ... PHILADELPHIA – United ...

DOJ Criminal Generic Pharma Price-Fixing Investigation Gathers ...

The DOJ Antitrust Division's multi-year criminal cartel investigation of the generic pharmaceutical industry is gaining steam.

Generic Pharmaceutical Company Pays $25 Million to Resolve ...

Generic Pharmaceutical Company Pays $25 Million to Resolve False Claims Act Liability for Price-Fixing of Generic Drugs ... PHILADELPHIA – U.S. ...

DOJ's Prosecution of Generic Drug Companies Continues as it ...

Over the past year, the DOJ has announced charges against a number of generic drug manufacturers. All have entered into settlements via deferred ...

Teva, Glenmark enter deferred prosecution deal DOJ over price fixing

Drugmaker Teva Pharmaceuticals agreed to pay $225 million in criminal fines over five years to resolve charges related to price fixing three ...

Raytheon Company to Pay Over $950M in Connection with ...

Raytheon also entered into a civil False Claims Act settlement to resolve allegations that it provided untruthful certified cost or pricing data ...

Heritage Pharmaceuticals Admits to Generic Drug Price Fixing ...

has entered into a deferred prosecution agreement (DPA) with DOJ. The terms of the DPA require Heritage to pay a $225000 criminal penalty ...

Corporate Resolutions 2023 Year-End Update - Gibson Dunn

In 2023, the US Department of Justice heavily favored plea agreements over non-prosecution agreements and deferred prosecution agreements to resolve corporate ...

A Rare Antitrust Deferred Prosecution Agreement From DOJ

resolving exposure resulting from the DOJ's long-running investigation into price-fixing in the generic drug industry. The DPA resolves ...

The US DoJ enters into deferred prosecution agreements to resolve ...

... announced on August 21, 2023 that it entered into deferred prosecution agreements (“DPAs”) resolving criminal price-fixing charges against Teva Pharmaceuticals…

United States: Cartels - Global Competition Review

Press Release, 'Pharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, Resolves Related False Claims Act Violations', DOJ ...